PCN51 Comprehensive Investigation of Adverse Event (AE)-Related Costs in Patients With Metastatic Breast Cancer (mBC) Treated With First- and Second-Line Chemotherapies

Abstract

Authors

S.A. Hurvitz A. Guerin M. Brammer E. Guardino Z.Y. Zhou M.S. Kaminsky E.Q. Wu D. Lalla